Health Care & Life Sciences » Biotechnology | InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp.
Stock Exchange NASDAQ Stock Market
EPS
$8.46
Market Cap
$7.26 M
Shares Outstanding
9.31 M
Public Float
9.28 M

Profile

Address
One Kendall Square
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.invivotherapeutics.com
Updated 07/08/2019
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of SCIs. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P.

Financials

View All
Created with Highcharts 5.0.14InVivo Therapeutics Holdings Corp.Net Income. Fiscal year is January-December. All values USD Thousands.38 75538 75518 34618 34633 31433 31423 43823 43826 74526 74523 42323 423201320142015201620172018010k20k30k40k50k

Richard Toselli
President, Chief Executive Officer & Director
C. Ann Merrifield
Chairman